5K
Downloads
14
Episodes
Discussing cancer with experts in the field in order to educate patients, families, and the general public. One of the most common complaints we hear from our patients when we first meet them to discuss their cancer diagnosis and treatment plan is that there is a lack of reliable, available information about cancer. Evaluating what is or isn’t a credible source of information on the internet is challenging, even for the most experienced of Googlers. We are seeking to fill that gap by providing the public with understandable, reliable information about cancer. Join us as we talk to healthcare experts at Ochsner about what you need to know should you or a loved one receive a cancer diagnosis.
Episodes
Thursday Jul 14, 2022
Thursday Jul 14, 2022
Liver cancer is one of the most common types of cancer worldwide and represents the third most common cause of cancer-related death globally. About 75% of liver cancers arise from the liver cells – and these cancers are called hepatocellular carcinoma, or HCC. The majority of the remaining liver cancers arise from the bile ducts that traverse the liver- and these cancers are referred to biliary tract cancers, or cholangiocarcinoma.
In this episode of the All In Against Cancer podcast powered by the Ochsner Cancer Institute, host Dr. Jonathan Mizrahi talks with Ochsner medical oncologist, Dr. Lingling Du, and Ochsner interventional radiologist, Dr. Tyler Sandow, about liver cancer.
Tune in to hear more about the approach to diagnosis, staging, treatment, prevention, and screening for liver cancer.
Comments (0)
To leave or reply to comments, please download free Podbean or
No Comments
To leave or reply to comments,
please download free Podbean App.